These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 1652714)

  • 41. Identification and characterization of muscarinic cholinergic receptors in the isolated plasma membranes and intact tissue of the urinary bladder.
    Batra S
    J Recept Res; 1986; 6(3-4):227-46. PubMed ID: 3806496
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Different agonist binding properties of M1 and M2 muscarinic receptors in calf brain cortex membranes.
    Vanderheyden P; Ebinger G; Vauquelin G
    Biochem Pharmacol; 1987 Dec; 36(23):4119-24. PubMed ID: 3689439
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Potency ratio for the inhibition of 3H-QNB and 3H-cis-methyldioxolane binding predicts agonist or antagonist activity on muscarinic receptors.
    Moret C; Pastrie I; Briley M
    Methods Find Exp Clin Pharmacol; 1988 Oct; 10(10):619-21. PubMed ID: 3236936
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of clozapine on rat striatal muscarinic receptors coupled to inhibition of adenylyl cyclase activity and on the human cloned m4 receptor.
    Olianas MC; Maullu C; Onali P
    Br J Pharmacol; 1997 Oct; 122(3):401-8. PubMed ID: 9351494
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mixed competitive and allosteric antagonism by gallamine of muscarinic receptor-mediated second messenger responses in N1E-115 neuroblastoma cells.
    Lee NH; el-Fakahany EE
    J Neurochem; 1989 Oct; 53(4):1300-8. PubMed ID: 2549200
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [3H]tricyclopinate binding to brain muscarinic acetylcholine receptors: a comparison with [3H]quinuclidinyl benzilate.
    Gao ZG; Liu CG
    Pharmacol Res; 1996; 33(4-5):283-9. PubMed ID: 8938022
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Binding kinetics of quinuclidinyl benzilate and methyl-quinuclidinyl benzilate enantiomers at neuronal (M1), cardiac (M2), and pancreatic (M3) muscarinic receptors.
    Waelbroeck M; Tastenoy M; Camus J; Christophe J
    Mol Pharmacol; 1991 Sep; 40(3):413-20. PubMed ID: 1896027
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Potential mechanisms involved in the negative coupling between serotonin 5-HT1A receptors and carbachol-stimulated phosphoinositide turnover in the rat hippocampus.
    Claustre Y; Benavides J; Scatton B
    J Neurochem; 1991 Apr; 56(4):1276-85. PubMed ID: 1848278
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Modulation of muscarinic cholinergic receptor affinity for antagonists in rat heart.
    Martin MW; Smith MM; Harden TK
    J Pharmacol Exp Ther; 1984 Aug; 230(2):424-30. PubMed ID: 6379149
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evidence for the coupling of muscarinic M3 receptor to cyclic AMP formation and poly-phosphatidylinositol turnover in rat salivary glands.
    Wei JW; Yeh SR; Wang EK
    Chin J Physiol; 1991; 34(3):303-15. PubMed ID: 1667096
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Differential effects of alkylating agents on the multiple muscarinic receptor subtypes linked to activation of phospholipase C by carbachol in rat brain cortical membranes.
    Sallés J; Wallace MA; Fain JN
    J Pharmacol Exp Ther; 1993 Feb; 264(2):521-9. PubMed ID: 8437104
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Non-neuronal cell-conditioned medium regulates muscarinic receptor expression in cultured sympathetic neurons.
    Smith KE; Kessler JA
    J Neurosci; 1988 Jul; 8(7):2406-13. PubMed ID: 3249233
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparative anticholinergic properties of thioridazine, mesoridazine and sulforidazine.
    Niedzwiecki DM; Cubeddu LX; Mailman RB
    J Pharmacol Exp Ther; 1989 Jul; 250(1):126-33. PubMed ID: 2746492
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Quinuclidinyl benzilate binding in house fly heads and rat brain.
    Jones SW; Sumikawa K
    J Neurochem; 1981 Feb; 36(2):454-9. PubMed ID: 7463072
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Muscarinic binding sites on bovine pulmonary arterial endothelial cells in culture.
    Aronstam RS; Ryan US; Catravas JD
    Pharmacology; 1992; 44(6):324-33. PubMed ID: 1508962
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Regulation of muscarinic receptor-mediated cyclic GMP synthesis by cultured mouse neuroblastoma cells.
    El-Fakahany E; Richelson E
    J Neurochem; 1980 Oct; 35(4):941-8. PubMed ID: 6109003
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of phospholipid hydrolysis by phospholipase A2 on the kinetics of antagonist binding to cardiac muscarinic receptors.
    Rauch B; Niroomand F; Messineo FC; Weis A; Kübler W; Hasselbach W
    Biochem Pharmacol; 1994 Sep; 48(6):1289-96. PubMed ID: 7945423
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Muscarinic receptors on intact human fibroblasts. Absence of receptor activity in adult skin cells.
    Van Riper DA; Absher MP; Lenox RH
    J Clin Invest; 1985 Aug; 76(2):882-6. PubMed ID: 2993368
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inhibition of phosphoinositide turnover by selective muscarinic antagonists in the rat striatum. Correlation with receptor occupancy.
    Monsma FJ; Abood LG; Hoss W
    Biochem Pharmacol; 1988 Jun; 37(12):2437-43. PubMed ID: 2839194
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Identification of direct competition for, and indirect influences on, striatal muscarinic cholinergic receptors: in vivo [3H]quinuclidinyl benzilate binding in rats.
    Pelham RW; Munsat TL
    Brain Res; 1979 Aug; 171(3):473-80. PubMed ID: 476482
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.